- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07579182
Hormones, Outcomes, and Pain Pathways in Exercise Study (HOPE)
Mechanical and Non-mechanical Contributions to Chronic Neck, Shoulder, Arm, and Back Pain in Full-busted Women
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Studietype
Registrering (Antatt)
Fase
- Fase 1
Kontakter og plasseringer
Studiekontakt
- Navn: Stacey L Gorniak, PhD
- Telefonnummer: 713-743-4802
- E-post: sgorniak@uh.edu
Studiesteder
-
-
Texas
-
Houston, Texas, Forente stater, 77204
- Rekruttering
- University of Houston
-
Ta kontakt med:
- Stacey L Gorniak, PhD
- Telefonnummer: 713-743-4802
- E-post: sgorniak@uh.edu
-
Hovedetterforsker:
- Stacey L Gorniak, PhD
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria:
- Able to provide informed consent
- Age of 18 to 60 years
- Assigned female sex at birth
- Right-handed by self-declaration
- Willing to participate in one online testing session and up to four in-person testing sessions
- Bra band size between 32-40"
- International Physical Activity Questionnaire - Short Form (IPAQ-SF) score of 2 or higher
- An answer of "NO" to any item of the general health questions of the PARQ+
- No history of surgery to the: back, neck, or shoulders or joint replacement
- No history of implanted pacemakers or other stimulation devices
- No history of spinal cord injury (SCI)
Exclusion Criteria:
- Inability to provide informed consent
- Age 17 years old or younger or 61 years or older
- Assigned male sex at birth
- Left-handed by self-declaration
- Not willing to participate in one online testing session and up to four in-person testing sessions
- Bra band size greater than 40" or less than 32"
- IPAQ-SF score of 1 or lower
- An answer of "YES" to any item of the general health questions of the PARQ+
- History of limb amputation (upper or lower extremity)
- Presence of open pressure sores on the upper or lower extremities
- Currently pregnant or lactating/breastfeeding
- History of surgery to the: back, neck, or shoulders or joint replacement
- History of breast cancer and/or mastectomy
- History of implanted pacemakers or other stimulation devices
- History of spinal cord injury (SCI)
- History of joint disease including osteoarthritis and/or Rheumatoid Arthritis
- History of the following neurological diseases: Cerebrovascular accident (CVA, stroke), Alzheimer's Disease (AD), Dementia (of any form), Huntington's Disease, Traumatic Brain Injury (TBI), Spinal cord injury (SCI), Multiple Sclerosis (MS), Parkinson's Disease (PD), Polio, Paraproteinaemic Demyelinating Neuropathy (PDN) and/or Monoclonal Gammopathy of Undetermined Significance (MGUS), Myasthenia Gravis, Muscular Dystrophy, Guillain-Barré Syndrome, Scoliosis, Charcot-Marie-Tooth Disorder or other hereditary neuropathies
Additional Inclusion Criteria for Intervention Group:
a. Self-declared breast size of D-I cup (US sizes: D, E, F, G, H)
Additional Inclusion Criteria for the Control Group:
a. Self-declared breast size of A-C cup (US sizes: AA, A, B, C)
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Grunnvitenskap
- Tildeling: Ikke-randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Dobbelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Ingen inngripen: Control
Women with bra cup sizes A - C. Control group will undergo measurement of kinematic and kinetic data during physical activities at baseline.
Study questionnaires, pain measures, body composition, brain activity, and blood-based biomarkers will be collected at baseline.
Physical activity will be tracked via smartwatch for 3 months after baseline.
|
|
|
Eksperimentell: Interventional Sports Bra
Women with bra cup sizes D - I. Intervention group will undergo measurement of kinematic and kinetic data during physical activities at baseline and 3 months after receiving their interventional sports bras.
Study questionnaires, pain measures, body composition, brain activity, and blood-based biomarkers will be collected at baseline and 3 months after receiving the interventional sports bras.
Physical activity will be tracked via smartwatch for 3 months after baseline.
|
This study involves use of observation and analysis of behavior in assessing breast motion and associated health outcomes while using a provided interventional sports bra of participant choice (Bounceless bra or Shefit Ultimate bra) for 3 months.
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Pain Measures
Tidsramme: Baseline and 3 months after baseline
|
Qualitative assessment of pain via self-report (no units)
|
Baseline and 3 months after baseline
|
|
Objective Pain Measure
Tidsramme: Baseline and 3 months after baseline
|
Nociceptive Flexion Reflex Threshold (mV)
|
Baseline and 3 months after baseline
|
|
Physical activity
Tidsramme: Baseline and 3 months after baseline
|
Frequency and duration of physical activity as measured via smartwatch
|
Baseline and 3 months after baseline
|
|
Anthropometry
Tidsramme: Baseline and 3 months after baseline
|
Percent body fat (%)
|
Baseline and 3 months after baseline
|
|
Anthropometry
Tidsramme: Baseline and 3 months after baseline
|
Body mass index (BMI) (kg/m²)
|
Baseline and 3 months after baseline
|
|
Glycated Hemoglobin
Tidsramme: Baseline and 3 months after baseline
|
A1c (%)
|
Baseline and 3 months after baseline
|
|
Lipids
Tidsramme: Baseline and 3 months after baseline
|
Total Cholesterol (mg/dL)
|
Baseline and 3 months after baseline
|
|
Lipids
Tidsramme: Baseline and 3 months after baseline
|
High Density Lipoprotein Cholesterol (HDL) (mg/dL)
|
Baseline and 3 months after baseline
|
|
Biomechanical Data
Tidsramme: Baseline and 3 months after baseline
|
Muscle activity (mV)
|
Baseline and 3 months after baseline
|
|
Neuroimaging Data
Tidsramme: Baseline and 3 months after baseline
|
Oxygenated Hemoglobin (HbO) (p-value)
|
Baseline and 3 months after baseline
|
|
Neuroimaging Data
Tidsramme: Baseline and 3 months after baseline
|
Deoxygenated Hemoglobin (HbR) (p-value)
|
Baseline and 3 months after baseline
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Blood Pressure
Tidsramme: Baseline and 3 months after baseline
|
Systole and Diastole (mmHg)
|
Baseline and 3 months after baseline
|
|
Systemic Inflammation Index
Tidsramme: Baseline and 3 months after baseline
|
SII (no units)
|
Baseline and 3 months after baseline
|
|
Neuroimaging Data
Tidsramme: Baseline and 3 months after baseline
|
Total Hemoglobin (HbT) (p-value)
|
Baseline and 3 months after baseline
|
|
Biomechanical Data
Tidsramme: Baseline and 3 months after baseline
|
Breast tissue acceleration (m/s2)
|
Baseline and 3 months after baseline
|
|
Biomechanical Data
Tidsramme: Baseline and 3 months after baseline
|
Gait speed (m/s)
|
Baseline and 3 months after baseline
|
|
Biomechanical Data
Tidsramme: Baseline and 3 months after baseline
|
Cadence (Hz)
|
Baseline and 3 months after baseline
|
|
Menopausal Status
Tidsramme: Baseline
|
Age at menopause (years) - if applicable
|
Baseline
|
|
Sex-Hormones
Tidsramme: Baseline and 3 months after baseline
|
Testosterone (mg/dL)
|
Baseline and 3 months after baseline
|
|
Sex-Hormones
Tidsramme: Baseline and 3 months after baseline
|
Estradiol (mg/dL)
|
Baseline and 3 months after baseline
|
|
Sex-Hormones
Tidsramme: Baseline and 3 months after baseline
|
Progesterone (mg/dL)
|
Baseline and 3 months after baseline
|
|
Sex-Hormones
Tidsramme: Baseline and 3 months after baseline
|
Follicle Stimulating Hormone (mg/dL)
|
Baseline and 3 months after baseline
|
|
Sex-Hormones
Tidsramme: Baseline and 3 months after baseline
|
Sex Hormone Binding Globulin (nmol/L)
|
Baseline and 3 months after baseline
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Etterforskere
- Hovedetterforsker: Stacey L Gorniak, PhD, University of Houston
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- STUDY00005233
- R01AR084021-01A1 (U.S. NIH-stipend/kontrakt)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
What data outputs will the research generate?
Biomechanical Evaluation Data Blood-based Biomarker Data (e.g., inflammation markers, sex-hormone values) Health State Data (e.g., blood pressure values, BMI, body composition values, menopausal status) Pain Data Physical Activity Data Functional Neuroimaging Data (t-values of Cortical Oxygenated, Deoxygenated, and Total Hemoglobin)
Manuscripts (which will also be publicly available via Pubmed upon publication)
IPD-delingstidsramme
Tilgangskriterier for IPD-deling
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .